Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.

Boston Scientific ($BSX) announced an update on their ongoing clinical study. Study OverviewThis global Boston Scientific trial, officially titled ...

Atrial fibrillation affects about 2.7 million Americans. It's a condition that causes heart palpitations, shortness of breath and dizziness - and if untreated, can be life-threatening. Now, doctors ...

Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Volt™ PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin ...

The Volt pulsed-field ablation (PFA) system (Abbott) has been approved by the US Food and Drug Administration for the treatment of patients with atrial fibrillation (AF), according to a Monday ...

A new clinical trial is now underway at the MGH to investigate whether combining two catheter-based procedures will improve the long-term outcome in the treatment of atrial fibrillation, the most ...

London, United Kingdom – 2 September 2024: A catheter ablation procedure widely used to treat the most common heart rhythm disorder significantly reduces the burden of atrial fibrillation (AF) and ...

It’s a condition that can make your heart race and put you at risk for stroke. But for some patients, medication can’t control atrial fibrillation. See how two top surgeons are teaming up to offer a ...

MANSFIELD - Patients in North Central Ohio who have a common form of irregular heartbeat known as atrial fibrillation now have a new option for treating their condition. OhioHealth Mansfield Hospital ...

Convergent hybrid ablation is an innovative treatment for a type of irregular heart rhythm called atrial fibrillation (AFib). The treatment is a two-stage procedure that combines the expertise of our ...